Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan combinations for hypertension
NCT00185120Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change in systolic blood pressure from the start of the study. Started Sep 2005; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00185120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185120.